GENE ONLINE|News &
Opinion
Blog

Gene Therapy
M&A Eli Lilly
Eli Lilly Snatches Up Akouos Treating Ear Conditions for $487 million
2022-10-18
Trials & Approvals Biomarin Pharmaceuticals
FDA Accepts Resubmission of BioMarin’s Gene Therapy Two Years After Rejection
2022-10-13
Pfizer Opts In On Neurological Target In Voyager Deal, Leaving $290 Million In Milestones
2022-10-05
Trials & Approvals Duchenne Muscular Dystrophy-dmd
Sarepta Submits BLA for First-Ever Duchenne Muscular Dystrophy Gene Therapy
2022-10-03
Feature Illumina
A New Sequencer on the Horizon – Illumina Genomics Forum Days Two and Three Highlights
2022-09-30
Special IlluminaGlobal Events
Illumina Genomics Forum Kicks Off With A Conversation With President Barack Obama
2022-09-29
Trials & Approvals Hemophilia A
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
Trials & Approvals Avrobio
AVROBIO’s First-of-its-Kind Gene Therapy Receives Rare Pediatric Disease Designation
2022-09-21
Trials & Approvals Gene Therapy
Bluebird’s Rare Childhood Neurodegenerative Gene Therapy Gains Accelerated Approval
2022-09-19
Special HIV
A Cure for HIV Could Be Here Sooner Than You Think – Future of Health
2022-09-16
Partnerships Charles River Laboratories
Charles River Laboratories Partners With Non-Profit in an Effort to Cure a Rare Disease
2022-09-06
Trials & Approvals bluebird bio
Bluebird Bio’s Zynteglo Becomes First FDA-Approved Gene Therapy For Beta-Thalassemia
2022-08-18
Trials & Approvals Gene Therapy
Gene Repair Therapy: First Patient Dosed With New Treatment for Sickle Cell Disease
2022-08-11
Special BIO2022
BIO 2022: Addressing Bottlenecks in Gene Therapy
2022-08-03
Trials & Approvals Wet Macular Degeneration
Adverum Advances Wet AMD Gene Therapy After Cutting Jobs
2022-07-18
1 2 3 4 … 9
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top